HALO
Halozyme Therape (HALO)
NASDAQ
$82.43-$0.12 (-0.14%)
Price as of Aug 03, 2026 6:05 AM EDT
  • $9.8B
    Market Cap
  • 39.85%
    1-Year Change
  • Biotechnology
    Industry
HALO
vs History
vs S&P 500
General Statistics
Latest Close
$82.54
Change
-$0.76 (-0.91%)
Open
$83.19
High
$83.27
Low
$81.50
Previous Close
$83.30
Volume
1,558,901
30-Day Average Volume
1,774,163
1-Week Change
0.74%
1-Month Change
5.46%
1-Year Change
39.85%
3-Year Change
92.13%
5-Year Change
99.71%
Fundamentals
Shares Outstanding
118.6M
Total Assets
$2.7B
Market Cap
$9.8B
Enterprise Value
$11.6B
Period:
QTR
TTM
FY
Revenue
$240.7M
Net Income
$150.0M
Free Cash Flow
$176.3M
EBIT
$180.7M
EBITDA
$210.2M
Net Working Capital
$639.8M
EPS
$1.22
Enterprise Value/EBITDA
55
Enterprise Value/Revenue
48
P/B
45
P/E
68
PEG
0
Price/Free Cash Flow
56
Price/Operating Cash Flow
54
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue